Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
VYGRVoyager Therapeutics, Inc.
| Figure | VYGRVoyager Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $40.37M |
| Revenue, yoy | −49.5% |
| Net income | $119.72M |
| Net income, yoy | −84.2% |
| Net margin | -296.5% |
| Free cash flow | $135.06M |
| FCF margin | -334.5% |
| EPS, diluted | $2.04 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed